SP1 and central nervous system cancer: Remarkably, Sp1 ChIP results revealed that Sp1-Gαi2 promoter binding 51 in various glioma cells (“P1-P3” primary cells and A172 cells) was substantially higher than it in Astrocytes1/2 (Figure 7G).